Fingerprint
Dive into the research topics of 'The full blood count as a biomarker of outcome and toxicity in ipilimumab-treated cutaneous metastatic melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The full blood count as a biomarker of outcome and toxicity in ipilimumab-treated cutaneous metastatic melanoma
Eshetu G Atenafu, Arnoud Templeton, Ye Qye, Mary Anne Chappell, Sam Saibil, David Hogg, Marcus O Butler, Anthony M Joshua, Leila Khoja
Research output: Contribution to journal › Article › peer-review
47
Citations
(Scopus)